{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "SARS-CoV-2", "antiviral agents", "coronavirus", "natural bioactive molecules", "therapeutic targets"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34483904", "DateRevised": {"Year": "2023", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "17"}], "Language": ["eng"], "ELocationID": ["702472", "10.3389/fphar.2021.702472"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2.", "Pagination": {"StartPage": "702472", "MedlinePgn": "702472"}, "Abstract": {"AbstractText": ["In the past two decades, pandemics of several fatal coronaviruses have posed enormous challenges for public health, including SARS-CoV (2003), MERS-CoV (2012), and SARS-CoV-2 (2019). Among these, SARS-CoV-2 continues to ravage the world today and has lead to millions of deaths and incalculable economic damage. Till now, there is no clinically proven antiviral drug available for SARS-CoV-2. However, the bioactive molecules of natural origin, especially medicinal plants, have been proven to be potential resources in the treatment of SARS-CoV-2, acting at different stages of the viral life cycle and targeting different viral or host proteins, such as PL<sup>pro</sup>, 3CL<sup>pro</sup>, RdRp, helicase, spike, ACE2, and TMPRSS2. They provide a viable strategy to develop therapeutic agents. This review presents fundamental biological information on SARS-CoV-2, including the viral biological characteristics and invasion mechanisms. It also summarizes the reported natural bioactive molecules with anti-coronavirus properties, arranged by their different targets in the life cycle of viral infection of human cells, and discusses the prospects of these bioactive molecules for the treatment of COVID-19."], "CopyrightInformation": "Copyright \u00a9 2021 Chen, Wang, Wang and Li."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China."}], "LastName": "Chen", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biobank, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China."}], "LastName": "Wang", "ForeName": "Zhihao", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biobank, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China."}, {"Identifier": [], "Affiliation": "Department of Laboratory Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China."}], "LastName": "Wang", "ForeName": "Yawen", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China."}], "LastName": "Li", "ForeName": "Yiping", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abian O., Ortega-Alarcon D., Jimenez-Alesanco A., Ceballos-Laita L., Vega S., Reyburn H. T., et al. (2020). Structural Stability of SARS-CoV-2 3CLpro and Identification of Quercetin as an Inhibitor by Experimental Screening. Int. J. Biol. Macromolecules 164, 1693\u20131703. 10.1016/j.ijbiomac.2020.07.235", "ArticleIdList": ["10.1016/j.ijbiomac.2020.07.235", "PMC7395220", "32745548"]}, {"Citation": "Adedeji A. O., Marchand B., Te Velthuis A. J. W., Snijder E. J., Weiss S., Eoff R. L., et al. (2012). Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase. PLoS One 7 (5), e36521. 10.1371/journal.pone.0036521", "ArticleIdList": ["10.1371/journal.pone.0036521", "PMC3352918", "22615777"]}, {"Citation": "Adnan M., Alshammari E., Ashraf S. A., Patel K., Lad K., Patel M. (2018a). Physiological and Molecular Characterization of Biosurfactant Producing Endophytic FungiXylaria Regalisfrom the Cones ofThuja Plicataas a Potent Plant Growth Promoter with its Potential Application. Biomed. Res. Int. 2018, 1\u201311. 10.1155/2018/7362148", "ArticleIdList": ["10.1155/2018/7362148", "PMC5971342", "29862287"]}, {"Citation": "Adnan M., Patel M., Deshpande S., Alreshidi M., Siddiqui A. J., Reddy M. N., et al. (2020). Effect of Adiantum Philippense Extract on Biofilm Formation, Adhesion with its Antibacterial Activities against Foodborne Pathogens, and Characterization of Bioactive Metabolites: An In Vitro-In Silico Approach. Front. Microbiol. 11, 823. 10.3389/fmicb.2020.00823", "ArticleIdList": ["10.3389/fmicb.2020.00823", "PMC7237743", "32477292"]}, {"Citation": "Adnan M., Patel M., Reddy M. N., Alshammari E. (2018b). Formulation, Evaluation and Bioactive Potential of Xylaria Primorskensis Terpenoid Nanoparticles from its Major Compound Xylaranic Acid. Sci. Rep. 8 (1), 1740. 10.1038/s41598-018-20237-z", "ArticleIdList": ["10.1038/s41598-018-20237-z", "PMC5789059", "29379181"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J. R., Hilgenfeld R. (2003). Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs. Science 300, 1763\u20131767. 10.1126/science.1085658", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Arabi Y. M., Balkhy H. H., Hayden F. G., Bouchama A., Luke T., Baillie J. K., et al. (2017). Middle East Respiratory Syndrome. N. Engl. J. Med. 376 (6), 584\u2013594. 10.1056/NEJMsr1408795", "ArticleIdList": ["10.1056/NEJMsr1408795", "PMC5362064", "28177862"]}, {"Citation": "Arndt A. L., Larson B. J., Hogue B. G. (2010). A Conserved Domain in the Coronavirus Membrane Protein Tail Is Important for Virus Assembly. J. Virol. 84, 11418\u201311428. 10.1128/jvi.01131-10", "ArticleIdList": ["10.1128/jvi.01131-10", "PMC2953170", "20719948"]}, {"Citation": "Atanasov A. G., Zotchev S. B., Zotchev S. B., Dirsch V. M., Supuran C. T. (2021). Natural Products in Drug Discovery: Advances and Opportunities. Nat. Rev. Drug Discov. 20 (3), 200\u2013216. 10.1038/s41573-020-00114-z", "ArticleIdList": ["10.1038/s41573-020-00114-z", "PMC7841765", "33510482"]}, {"Citation": "Bailly C., Vergoten G. (2020). Glycyrrhizin: An Alternative Drug for the Treatment of COVID-19 Infection and the Associated Respiratory Syndrome?. Pharmacol. Ther. 214, 107618. 10.1016/j.pharmthera.2020.107618", "ArticleIdList": ["10.1016/j.pharmthera.2020.107618", "PMC7311916", "32592716"]}, {"Citation": "Bhardwaj K., Sun J., Holzenburg A., Guarino L. A., Kao C. C. (2006). RNA Recognition and Cleavage by the SARS Coronavirus Endoribonuclease. J. Mol. Biol. 361 (2), 243\u2013256. 10.1016/j.jmb.2006.06.021", "ArticleIdList": ["10.1016/j.jmb.2006.06.021", "PMC7118729", "16828802"]}, {"Citation": "Bouvet M., Imbert I., Subissi L., Gluais L., Canard B., Decroly E. (2012). RNA 3'-end Mismatch Excision by the Severe Acute Respiratory Syndrome Coronavirus Nonstructural Protein Nsp10/nsp14 Exoribonuclease Complex. Proc. Natl. Acad. Sci. 109, 9372\u20139377. 10.1073/pnas.1201130109", "ArticleIdList": ["10.1073/pnas.1201130109", "PMC3386072", "22635272"]}, {"Citation": "Bouvet M., Lugari A., Posthuma C. C., Zevenhoven J. C., Bernard S., Betzi S., et al. (2014). Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes. J. Biol. Chem. 289 (37), 25783\u201325796. 10.1074/jbc.M114.577353", "ArticleIdList": ["10.1074/jbc.M114.577353", "PMC4162180", "25074927"]}, {"Citation": "Ceraolo C., Giorgi F. M. (2020). Genomic Variance of the 2019\u2010nCoV Coronavirus. J. Med. Virol. 92 (5), 522\u2013528. 10.1002/jmv.25700", "ArticleIdList": ["10.1002/jmv.25700", "PMC7166773", "32027036"]}, {"Citation": "Chan J. F.-W., Kok K.-H., Zhu Z., Chu H., To K. K.-W., Yuan S., et al. (2020). Genomic Characterization of the 2019 Novel Human-Pathogenic Coronavirus Isolated from a Patient with Atypical Pneumonia after Visiting Wuhan. Emerging Microbes & Infections 9 (1), 221\u2013236. 10.1080/22221751.2020.1719902", "ArticleIdList": ["10.1080/22221751.2020.1719902", "PMC7067204", "31987001"]}, {"Citation": "Chang C.-k., Hou M.-H., Chang C.-F., Hsiao C.-D., Huang T.-h. (2014). The SARS Coronavirus Nucleocapsid Protein - Forms and Functions. Antiviral Res. 103, 39\u201350. 10.1016/j.antiviral.2013.12.009", "ArticleIdList": ["10.1016/j.antiviral.2013.12.009", "PMC7113676", "24418573"]}, {"Citation": "Chellapandi P., Saranya S. (2020). Genomics Insights of SARS-CoV-2 (COVID-19) into Target-Based Drug Discovery. Med. Chem. Res. 29, 1777\u20131791. 10.1007/s00044-020-02610-8", "ArticleIdList": ["10.1007/s00044-020-02610-8", "PMC7394272", "32837137"]}, {"Citation": "Chen C.-N., Lin C. P. C., Huang K.-K., Chen W.-C., Hsieh H.-P., Liang P.-H., et al. (2005). Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-Digallate (TF3). Evidence-Based Complement. Altern. Med. 2 (2), 209\u2013215. 10.1093/ecam/neh081", "ArticleIdList": ["10.1093/ecam/neh081", "PMC1142193", "15937562"]}, {"Citation": "Chen L., Li J., Luo C., Liu H., Xu W., Chen G., et al. (2006). Binding Interaction of Quercetin-3-\u03b2-Galactoside and its Synthetic Derivatives with SARS-CoV 3CLpro: Structure-Activity Relationship Studies Reveal Salient Pharmacophore Features. Bioorg. Med. Chem. 14 (24), 8295\u20138306. 10.1016/j.bmc.2006.09.014", "ArticleIdList": ["10.1016/j.bmc.2006.09.014", "PMC7125754", "17046271"]}, {"Citation": "Chen X., Yang X., Zheng Y., Yang Y., Xing Y., Chen Z. (2014). SARS Coronavirus Papain-like Protease Inhibits the Type I Interferon Signaling Pathway through Interaction with the STING-TRAF3-TBK1 Complex. Protein Cell 5 (5), 369\u2013381. 10.1007/s13238-014-0026-3", "ArticleIdList": ["10.1007/s13238-014-0026-3", "PMC3996160", "24622840"]}, {"Citation": "Chen Y., Cai H., Pan J., Xiang N., Tien P., Ahola T., et al. (2009). Functional Screen Reveals SARS Coronavirus Nonstructural Protein Nsp14 as a Novel Cap N7 Methyltransferase. Proc. Natl. Acad. Sci. 106, 3484\u20133489. 10.1073/pnas.0808790106", "ArticleIdList": ["10.1073/pnas.0808790106", "PMC2651275", "19208801"]}, {"Citation": "Chen Z., Cui Q., Cooper L., Zhang P., Lee H., Chen Z., et al. (2021). Ginkgolic Acid and Anacardic Acid Are Specific Covalent Inhibitors of SARS-CoV-2 Cysteine Proteases. Cell Biosci. 11 (1), 45. 10.1186/s13578-021-00564-x", "ArticleIdList": ["10.1186/s13578-021-00564-x", "PMC7914117", "33640032"]}, {"Citation": "Cho J. K., Curtis-Long M. J., Lee K. H., Kim D. W., Ryu H. W., Yuk H. J., et al. (2013). Geranylated Flavonoids Displaying SARS-CoV Papain-like Protease Inhibition from the Fruits of Paulownia Tomentosa. Bioorg. Med. Chem. 21 (11), 3051\u20133057. 10.1016/j.bmc.2013.03.027", "ArticleIdList": ["10.1016/j.bmc.2013.03.027", "PMC7126831", "23623680"]}, {"Citation": "Chou K.-C., Wei D.-Q., Zhong W.-Z. (2003). Binding Mechanism of Coronavirus Main Proteinase with Ligands and its Implication to Drug Design against SARS. Biochem. Biophysical Res. Commun. 308 (1), 148\u2013151. 10.1016/s0006-291x(03)01342-1", "ArticleIdList": ["10.1016/s0006-291x(03)01342-1", "PMC7111004", "12890493"]}, {"Citation": "Christy M. P., Uekusa Y., Gerwick L., Gerwick W. H. (2021). Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2. J. Nat. Prod. 84 (1), 161\u2013182. 10.1021/acs.jnatprod.0c00968", "ArticleIdList": ["10.1021/acs.jnatprod.0c00968", "PMC7771248", "33352046"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. (2003). Glycyrrhizin, an Active Component of Liquorice Roots, and Replication of SARS-Associated Coronavirus. The Lancet 361 (9374), 2045\u20132046. 10.1016/s0140-6736(03)13615-x", "ArticleIdList": ["10.1016/s0140-6736(03)13615-x", "PMC7112442", "12814717"]}, {"Citation": "Cleri D. J., Ricketti A. J., Vernaleo J. R. (2010). Severe Acute Respiratory Syndrome (SARS). Infect. Dis. Clin. North America 24 (1), 175\u2013202. 10.1016/j.idc.2009.10.005", "ArticleIdList": ["10.1016/j.idc.2009.10.005", "PMC7135483", "20171552"]}, {"Citation": "Coelho C., Gallo G., Campos C. B., Hardy L., W\u00fcrtele M. (2020). Biochemical Screening for SARS-CoV-2 Main Protease Inhibitors. PLoS One 15 (10), e0240079. 10.1371/journal.pone.0240079", "ArticleIdList": ["10.1371/journal.pone.0240079", "PMC7537881", "33022015"]}, {"Citation": "Deb Majumdar I., Devanabanda A., Fox B., Schwartzman J., Cong H., Porco J. A., Jr., et al. (2011). Synthetic Cyclohexenyl Chalcone Natural Products Possess Cytotoxic Activities against Prostate Cancer Cells and Inhibit Cysteine Cathepsins In Vitro . Biochem. Biophysical Res. Commun. 416 (3-4), 397\u2013402. 10.1016/j.bbrc.2011.11.052", "ArticleIdList": ["10.1016/j.bbrc.2011.11.052", "22120630"]}, {"Citation": "Decroly E., Debarnot C., Ferron F., Bouvet M., Coutard B., Imbert I., et al. (2011). Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2\u2032-O-Methyltransferase Nsp10/nsp16 Complex. Plos Pathog. 7 (5), e1002059. 10.1371/journal.ppat.1002059", "ArticleIdList": ["10.1371/journal.ppat.1002059", "PMC3102710", "21637813"]}, {"Citation": "Decroly E., Imbert I., Coutard B., Bouvet M., Selisko B., Alvarez K., et al. (2008). Coronavirus Nonstructural Protein 16 Is a Cap-0 Binding Enzyme Possessing (Nucleoside-2\u2032 O )-Methyltransferase Activity. J. Virol. 82 (16), 8071\u20138084. 10.1128/JVI.00407-08", "ArticleIdList": ["10.1128/JVI.00407-08", "PMC2519555", "18417574"]}, {"Citation": "Fan H.-H., Wang L.-Q., Liu W.-L., An X.-P., Liu Z.-D., He X.-Q., et al. (2020). Repurposing of Clinically Approved Drugs for Treatment of Coronavirus Disease 2019 in a 2019-novel Coronavirus-Related Coronavirus Model. Chin. Med. J. (Engl) 133 (9), 1051\u20131056. 10.1097/CM9.0000000000000797", "ArticleIdList": ["10.1097/CM9.0000000000000797", "PMC7147283", "32149769"]}, {"Citation": "Fehr A. R., Perlman S. (2015). \u201cCoronaviruses: An Overview of Their Replication and Pathogenesis,\u201d in Coronaviruses: Methods and Protocols. Editors Maier H.J., Bickerton E., Britton P. (New York, NY: Springer New York; ), 1\u201323. 10.1007/978-1-4939-2438-7_1", "ArticleIdList": ["10.1007/978-1-4939-2438-7_1", "PMC4369385", "25720466"]}, {"Citation": "Fern\u00e1ndez-Quintela A., Milton-Laskibar I., Trepiana J., G\u00f3mez-Zorita S., Kajarabille N., L\u00e9niz A., et al. (2020). Key Aspects in Nutritional Management of COVID-19 Patients. Jcm 9 (8), 2589. 10.3390/jcm9082589", "ArticleIdList": ["10.3390/jcm9082589", "PMC7463687", "32785121"]}, {"Citation": "Fung K. P., Leung P. C., Tsui K. W., Wan C. C., Wong K. B., Waye M. Y., et al. (2011). Immunomodulatory Activities of the Herbal Formula Kwan Du Bu Fei Dang in Healthy Subjects: a Randomised, Double-Blind, Placebo-Controlled Study. Hong Kong Med. J. 17 (Suppl. 2), 41\u201343.", "ArticleIdList": ["21368336"]}, {"Citation": "Fung T. S., Liu D. X. (2019). Human Coronavirus: Host-Pathogen Interaction. Annu. Rev. Microbiol. 73, 529\u2013557. 10.1146/annurev-micro-020518-115759", "ArticleIdList": ["10.1146/annurev-micro-020518-115759", "31226023"]}, {"Citation": "Gangadevi S., Badavath V. N., Thakur A., Yin N., De Jonghe S., Acevedo O., et al. (2021). Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19. J. Phys. Chem. Lett. 12 (7), 1793\u20131802. 10.1021/acs.jpclett.0c03119", "ArticleIdList": ["10.1021/acs.jpclett.0c03119", "33577324"]}, {"Citation": "Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.-C., Turner A. J., et al. (2020). Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System. Circ. Res. 126 (10), 1456\u20131474. 10.1161/CIRCRESAHA.120.317015", "ArticleIdList": ["10.1161/CIRCRESAHA.120.317015", "PMC7188049", "32264791"]}, {"Citation": "Gordon D. E., Jang G. M., Bouhaddou M., Xu J., Obernier K., White K. M., et al. (2020). A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing. Nature 583 (7816), 459\u2013468. 10.1038/s41586-020-2286-9", "ArticleIdList": ["10.1038/s41586-020-2286-9", "PMC7431030", "32353859"]}, {"Citation": "Habtemariam S., Nabavi S. F., Berindan\u2010Neagoe I., Cismaru C. A., Izadi M., Sureda A., et al. (2020). Should We Try the Antiinflammatory Natural Product, Celastrol, for COVID \u201019?. Phytotherapy Res. 34 (6), 1189\u20131190. 10.1002/ptr.6711", "ArticleIdList": ["10.1002/ptr.6711", "PMC7267639", "32347602"]}, {"Citation": "Hashimoto T., Perlot T., Rehman A., Trichereau J., Ishiguro H., Paolino M., et al. (2012). ACE2 Links Amino Acid Malnutrition to Microbial Ecology and Intestinal Inflammation. Nature 487 (7408), 477\u2013481. 10.1038/nature11228", "ArticleIdList": ["10.1038/nature11228", "PMC7095315", "22837003"]}, {"Citation": "Hatakeyama S., Matsuoka Y., Ueshiba H., Komatsu N., Itoh K., Shichijo S., et al. (2008). Dissection and Identification of Regions Required to Form Pseudoparticles by the Interaction between the Nucleocapsid (N) and Membrane (M) Proteins of SARS Coronavirus. Virology 380 (1), 99\u2013108. 10.1016/j.virol.2008.07.012", "ArticleIdList": ["10.1016/j.virol.2008.07.012", "PMC7103410", "18703211"]}, {"Citation": "Ho T., Wu S., Chen J., Li C., Hsiang C. (2007). Emodin Blocks the SARS Coronavirus Spike Protein and Angiotensin-Converting Enzyme 2 Interaction. Antiviral Res. 74 (2), 92\u2013101. 10.1016/j.antiviral.2006.04.014", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., et al. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181 (2), 271\u2013280. 10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Hu B., Guo H., Zhou P., Shi Z.-L. (2020). Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141\u2013154. 10.1038/s41579-020-00459-7", "ArticleIdList": ["10.1038/s41579-020-00459-7", "PMC7537588", "33024307"]}, {"Citation": "Huang C., Lokugamage K. G., Rozovics J. M., Narayanan K., Semler B. L., Makino S. (2011). SARS Coronavirus Nsp1 Protein Induces Template-dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to Nsp1-Induced RNA Cleavage. Plos Pathog. 7 (12), e1002433. 10.1371/journal.ppat.1002433", "ArticleIdList": ["10.1371/journal.ppat.1002433", "PMC3234236", "22174690"]}, {"Citation": "Hughes J., Rees S., Kalindjian S., Philpott K. (2011). Principles of Early Drug Discovery. Br. J. Pharmacol. 162 (6), 1239\u20131249. 10.1111/j.1476-5381.2010.01127.x", "ArticleIdList": ["10.1111/j.1476-5381.2010.01127.x", "PMC3058157", "21091654"]}, {"Citation": "Hui D. S. (2017). Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). Clin. Chest Med. 38 (1), 71\u201386. 10.1016/j.ccm.2016.11.007", "ArticleIdList": ["10.1016/j.ccm.2016.11.007", "PMC7131795", "28159163"]}, {"Citation": "Imbert I., Guillemot J.-C., Bourhis J.-M., Bussetta C., Coutard B., Egloff M.-P., et al. (2006). A Second, Non-canonical RNA-dependent RNA Polymerase in SARS Coronavirus. EMBO J. 25 (20), 4933\u20134942. 10.1038/sj.emboj.7601368", "ArticleIdList": ["10.1038/sj.emboj.7601368", "PMC1618104", "17024178"]}, {"Citation": "Imbert I., Snijder E. J., Dimitrova M., Guillemot J.-C., L\u00e9cine P., Canard B. (2008). The SARS-Coronavirus PLnc Domain of Nsp3 as a Replication/transcription Scaffolding Protein. Virus. Res. 133 (2), 136\u2013148. 10.1016/j.virusres.2007.11.017", "ArticleIdList": ["10.1016/j.virusres.2007.11.017", "PMC7114086", "18255185"]}, {"Citation": "Ivanov K. A., Rozanov M., Bayer S., Thiel V., Gorbalenya A. E., Ziebuhr J. (2004a). Major Genetic Marker of Nidoviruses Encodes a Replicative Endoribonuclease. Proc. Natl. Acad. Sci. 101, 12694\u201312699. 10.1073/pnas.0403127101", "ArticleIdList": ["10.1073/pnas.0403127101", "PMC514660", "15304651"]}, {"Citation": "Ivanov K. A., Thiel V., Dobbe J. C., van der Meer Y., Snijder E. J., Ziebuhr J. (2004b). Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase. J. Virol. 78 (11), 5619\u20135632. 10.1128/JVI.78.11.5619-5632.2004", "ArticleIdList": ["10.1128/JVI.78.11.5619-5632.2004", "PMC415832", "15140959"]}, {"Citation": "Jo S., Kim H., Kim S., Shin D. H., Kim M. S. (2019). Characteristics of Flavonoids as Potent MERS\u2010CoV 3C\u2010like Protease Inhibitors. Chem. Biol. Drug Des. 94 (6), 2023\u20132030. 10.1111/cbdd.13604", "ArticleIdList": ["10.1111/cbdd.13604", "PMC7162010", "31436895"]}, {"Citation": "Jo S., Kim S., Shin D. H., Kim M.-S. (2020). Inhibition of SARS-CoV 3CL Protease by Flavonoids. J. Enzyme Inhib. Med. Chem. 35 (1), 145\u2013151. 10.1080/14756366.2019.1690480", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Kamitani W., Narayanan K., Huang C., Lokugamage K., Ikegami T., Ito N., et al. (2006). Severe Acute Respiratory Syndrome Coronavirus Nsp1 Protein Suppresses Host Gene Expression by Promoting Host mRNA Degradation. Proc. Natl. Acad. Sci. 103, 12885\u201312890. 10.1073/pnas.0603144103", "ArticleIdList": ["10.1073/pnas.0603144103", "PMC1568942", "16912115"]}, {"Citation": "Kanjanasirirat P., Suksatu A., Manopwisedjaroen S., Munyoo B., Tuchinda P., Jearawuttanakul K., et al. (2020). High-content Screening of Thai Medicinal Plants Reveals Boesenbergia Rotunda Extract and its Component Panduratin A as Anti-SARS-CoV-2 Agents. Sci. Rep. 10 (1), 19963. 10.1038/s41598-020-77003-3", "ArticleIdList": ["10.1038/s41598-020-77003-3", "PMC7672115", "33203926"]}, {"Citation": "Khan A., Heng W., Wang Y., Qiu J., Wei X., Peng S., et al. (2021). In Silico and In Vitro Evaluation of Kaempferol as a Potential Inhibitor of the SARS\u2010CoV \u20102 Main Protease ( 3CLpro ). Phytotherapy Res. 35, 2841\u20132845. 10.1002/ptr.6998", "ArticleIdList": ["10.1002/ptr.6998", "PMC8013176", "33448101"]}, {"Citation": "Kim D. W., Seo K. H., Curtis-Long M. J., Oh K. Y., Oh J.-W., Cho J. K., et al. (2014). Phenolic Phytochemical Displaying SARS-CoV Papain-like Protease Inhibition from the Seeds of Psoralea Corylifolia. J. Enzyme Inhib. Med. Chem. 29 (1), 59\u201363. 10.3109/14756366.2012.753591", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Kirchdoerfer R. N., Ward A. B. (2019). Structure of the SARS-CoV Nsp12 Polymerase Bound to Nsp7 and Nsp8 Co-factors. Nat. Commun. 10 (1), 2342. 10.1038/s41467-019-10280-3", "ArticleIdList": ["10.1038/s41467-019-10280-3", "PMC6538669", "31138817"]}, {"Citation": "Kopecky-Bromberg S. A., Mart\u00ednez-Sobrido L., Frieman M., Baric R. A., Palese P. (2007). Severe Acute Respiratory Syndrome Coronavirus Open reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists. J. Virol. 81 (2), 548\u2013557. 10.1128/jvi.01782-06", "ArticleIdList": ["10.1128/jvi.01782-06", "PMC1797484", "17108024"]}, {"Citation": "Kumaki Y., Wandersee M. K., Smith A. J., Zhou Y., Simmons G., Nelson N. M., et al. (2011). Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication in a Lethal SARS-CoV BALB/c Mouse Model by Stinging Nettle Lectin, Urtica Dioica Agglutinin. Antiviral Res. 90 (1), 22\u201332. 10.1016/j.antiviral.2011.02.003", "ArticleIdList": ["10.1016/j.antiviral.2011.02.003", "PMC3085190", "21338626"]}, {"Citation": "Kwan J. C., Liu Y., Ratnayake R., Hatano R., Kuribara A., Morimoto C., et al. (2014). Grassypeptolides as Natural Inhibitors of Dipeptidyl Peptidase 8 and T-Cell Activation. Chembiochem 15 (6), 799\u2013804. 10.1002/cbic.201300762", "ArticleIdList": ["10.1002/cbic.201300762", "PMC4050061", "24591193"]}, {"Citation": "Lee C., Lee J. M., Lee N.-R., Jin B.-S., Jang K. J., Kim D.-E., et al. (2009a). Aryl Diketoacids (ADK) Selectively Inhibit Duplex DNA-Unwinding Activity of SARS Coronavirus NTPase/helicase. Bioorg. Med. Chem. Lett. 19 (6), 1636\u20131638. 10.1016/j.bmcl.2009.02.010", "ArticleIdList": ["10.1016/j.bmcl.2009.02.010", "PMC7127030", "19233643"]}, {"Citation": "Lee C., Lee J. M., Lee N.-R., Kim D.-E., Jeong Y.-J., Chong Y. (2009b). Investigation of the Pharmacophore Space of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) NTPase/helicase by Dihydroxychromone Derivatives. Bioorg. Med. Chem. Lett. 19 (16), 4538\u20134541. 10.1016/j.bmcl.2009.07.009", "ArticleIdList": ["10.1016/j.bmcl.2009.07.009", "PMC7127646", "19625187"]}, {"Citation": "Lee N.-R., Kwon H.-M., Park K., Oh S., Jeong Y.-J., Kim D.-E. (2010). Cooperative Translocation Enhances the Unwinding of Duplex DNA by SARS Coronavirus Helicase nsP13. Nucleic Acids Res. 38 (21), 7626\u20137636. 10.1093/nar/gkq647", "ArticleIdList": ["10.1093/nar/gkq647", "PMC2995068", "20671029"]}, {"Citation": "Lee Y.-S., Kang O.-H., Choi J.-G., Oh Y.-C., Chae H.-S., Kim J. H., et al. (2008). Synergistic Effects of the Combination of Galangin with Gentamicin against Methicillin-Resistant Staphylococcus aureus . J. Microbiol. 46 (3), 283\u2013288. 10.1007/s12275-008-0012-7", "ArticleIdList": ["10.1007/s12275-008-0012-7", "18604497"]}, {"Citation": "Lei J., Kusov Y., Hilgenfeld R. (2018). Nsp3 of Coronaviruses: Structures and Functions of a Large Multi-Domain Protein. Antiviral Res. 149, 58\u201374. 10.1016/j.antiviral.2017.11.001", "ArticleIdList": ["10.1016/j.antiviral.2017.11.001", "PMC7113668", "29128390"]}, {"Citation": "Li J.-y., Cao H.-y., Liu P., Cheng G.-h., Sun M.-y. (2014). Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review. Biomed. Res. Int. 2014, 1\u201315. 10.1155/2014/872139", "ArticleIdList": ["10.1155/2014/872139", "PMC4052927", "24963489"]}, {"Citation": "Li S., Chen C., Zhang H., Guo H., Wang H., Wang L., et al. (2005). Identification of Natural Compounds with Antiviral Activities against SARS-Associated Coronavirus. Antiviral Res. 67 (1), 18\u201323. 10.1016/j.antiviral.2005.02.007", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Li W., Moore M. J., Vasilieva N., Sui J., Wong S. K., Berne M. A., et al. (2003). Angiotensin-converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus. Nature 426 (6965), 450\u2013454. 10.1038/nature02145", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Lin C.-W., Tsai F.-J., Tsai C.-H., Lai C.-C., Wan L., Ho T.-Y., et al. (2005). Anti-SARS Coronavirus 3C-like Protease Effects of Isatis Indigotica Root and Plant-Derived Phenolic Compounds. Antiviral Res. 68 (1), 36\u201342. 10.1016/j.antiviral.2005.07.002", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Liu D. X., Yuan Q., Liao Y. (2007). Coronavirus Envelope Protein: A Small Membrane Protein with Multiple Functions. Cell. Mol. Life Sci. 64 (16), 2043\u20132048. 10.1007/s00018-007-7103-1", "ArticleIdList": ["10.1007/s00018-007-7103-1", "PMC7079843", "17530462"]}, {"Citation": "Loizzo M. R., Said A., Tundis R., Rashed K., Statti G. A., Hufner A., et al. (2007). Inhibition of Angiotensin Converting Enzyme (ACE) by Flavonoids Isolated fromAilanthus Excelsa (Roxb) (Simaroubaceae). Phytother. Res. 21 (1), 32\u201336. 10.1002/ptr.2008", "ArticleIdList": ["10.1002/ptr.2008", "17072829"]}, {"Citation": "Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. (2020). Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. The Lancet 395 (10224), 565\u2013574. 10.1016/s0140-6736(20)30251-8", "ArticleIdList": ["10.1016/s0140-6736(20)30251-8", "PMC7159086", "32007145"]}, {"Citation": "Lu W., Zheng B.-J., Xu K., Schwarz W., Du L., Wong C. K. L., et al. (2006). Severe Acute Respiratory Syndrome-Associated Coronavirus 3a Protein Forms an Ion Channel and Modulates Virus Release. Proc. Natl. Acad. Sci. 103 (33), 12540\u201312545. 10.1073/pnas.0605402103", "ArticleIdList": ["10.1073/pnas.0605402103", "PMC1567914", "16894145"]}, {"Citation": "Lugari A., Betzi S., Decroly E., Bonnaud E., Hermant A., Guillemot J.-C., et al. (2010). Molecular Mapping of the RNA Cap 2\u2032-O-Methyltransferase Activation Interface between Severe Acute Respiratory Syndrome Coronavirus Nsp10 and Nsp16*. J. Biol. Chem. 285 (43), 33230\u201333241. 10.1074/jbc.M110.120014", "ArticleIdList": ["10.1074/jbc.M110.120014", "PMC2963367", "20699222"]}, {"Citation": "Luo P., Liu D., Li J. (2020). Pharmacological Perspective: Glycyrrhizin May Be an Efficacious Therapeutic Agent for COVID-19. Int. J. Antimicrob. Agents 55 (6), 105995. 10.1016/j.ijantimicag.2020.105995", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105995", "PMC7180159", "32335281"]}, {"Citation": "Luo W., Su X., Gong S., Qin Y., Liu W., Li J., et al. (2009). Anti-SARS Coronavirus 3C-like Protease Effects of Rheum Palmatum L. Extracts. Biosci. Trends 3 (4), 124\u2013126.", "ArticleIdList": ["20103835"]}, {"Citation": "Ma-Lauer Y., Carbajo-Lozoya J., Hein M. Y., M\u00fcller M. A., Deng W., Lei J., et al. (2016). p53 Down-Regulates SARS Coronavirus Replication and Is Targeted by the SARS-Unique Domain and PLprovia E3 Ubiquitin Ligase RCHY1. Proc. Natl. Acad. Sci. USA 113 (35), E5192\u2013E5201. 10.1073/pnas.1603435113", "ArticleIdList": ["10.1073/pnas.1603435113", "PMC5024628", "27519799"]}, {"Citation": "Mandadi N. R., Mohd A., Mousa M. A., Mohd S., Mitesh P. (2020). Evaluation of Anticancer, Antibacterial and Antioxidant Properties of a Medicinally Treasured Fern Tectaria Coadunata with its Phytoconstituents Analysis by HR-LCMS. Anti-Cancer Agents Med. Chem. 20 (15), 1845\u20131856. 10.2174/1871520620666200318101938", "ArticleIdList": ["10.2174/1871520620666200318101938", "32188388"]}, {"Citation": "Masters P. S. (2006). The Molecular Biology of Coronaviruses. Adv. Virus Res. 66, 193\u2013292. 10.1016/S0065-3527(06)66005-3", "ArticleIdList": ["10.1016/S0065-3527(06)66005-3", "PMC7112330", "16877062"]}, {"Citation": "Matsuyama S., Nao N., Shirato K., Kawase M., Saito S., Takayama I., et al. (2020). Enhanced Isolation of SARS-CoV-2 by TMPRSS2-Expressing Cells. Proc. Natl. Acad. Sci. USA 117 (13), 7001\u20137003. 10.1073/pnas.2002589117", "ArticleIdList": ["10.1073/pnas.2002589117", "PMC7132130", "32165541"]}, {"Citation": "McBride R., Van Zyl M., Fielding B. (2014). The Coronavirus Nucleocapsid Is a Multifunctional Protein. Viruses 6 (8), 2991\u20133018. 10.3390/v6082991", "ArticleIdList": ["10.3390/v6082991", "PMC4147684", "25105276"]}, {"Citation": "Michel C. J., Mayer C., Poch O., Thompson J. D. (2020). Characterization of Accessory Genes in Coronavirus Genomes. Virol. J. 17 (1), 131. 10.1186/s12985-020-01402-1", "ArticleIdList": ["10.1186/s12985-020-01402-1", "PMC7450977", "32854725"]}, {"Citation": "Miller B., Friedman A. J., Choi H., Hogan J., McCammon J. A., Hook V., et al. (2014). The marine Cyanobacterial Metabolite Gallinamide A Is a Potent and Selective Inhibitor of Human Cathepsin L. J. Nat. Prod. 77 (1), 92\u201399. 10.1021/np400727r", "ArticleIdList": ["10.1021/np400727r", "PMC3932306", "24364476"]}, {"Citation": "Millet J. K., S\u00e9ron K., Labitt R. N., Danneels A., Palmer K. E., Whittaker G. R., et al. (2016). Middle East Respiratory Syndrome Coronavirus Infection Is Inhibited by Griffithsin. Antiviral Res. 133, 1\u20138. 10.1016/j.antiviral.2016.07.011", "ArticleIdList": ["10.1016/j.antiviral.2016.07.011", "PMC7113895", "27424494"]}, {"Citation": "Millet J. K., Whittaker G. R. (2015). Host Cell Proteases: Critical Determinants of Coronavirus Tropism and Pathogenesis. Virus. Res. 202, 120\u2013134. 10.1016/j.virusres.2014.11.021", "ArticleIdList": ["10.1016/j.virusres.2014.11.021", "PMC4465284", "25445340"]}, {"Citation": "Mitchell C. A., Ramessar K., O'Keefe B. R. (2017). Antiviral Lectins: Selective Inhibitors of Viral Entry. Antiviral Res. 142, 37\u201354. 10.1016/j.antiviral.2017.03.007", "ArticleIdList": ["10.1016/j.antiviral.2017.03.007", "PMC5414728", "28322922"]}, {"Citation": "Muhseen Z. T., Hameed A. R., Al-Hasani H. M. H., Tahir Ul Qamar M., Li G. (2020). Promising Terpenes as SARS-CoV-2 Spike Receptor-Binding Domain (RBD) Attachment Inhibitors to the Human ACE2 Receptor: Integrated Computational Approach. J. Mol. Liquids 320, 114493. 10.1016/j.molliq.2020.114493", "ArticleIdList": ["10.1016/j.molliq.2020.114493", "PMC7538380", "33041407"]}, {"Citation": "Narayanan K., Huang C., Lokugamage K., Kamitani W., Ikegami T., Tseng C.-T. K., et al. (2008). Severe Acute Respiratory Syndrome Coronavirus Nsp1 Suppresses Host Gene Expression, Including that of Type I Interferon, in Infected Cells. J. Virol. 82 (9), 4471\u20134479. 10.1128/JVI.02472-07", "ArticleIdList": ["10.1128/JVI.02472-07", "PMC2293030", "18305050"]}, {"Citation": "Nguyen T. T. H., Woo H.-J., Kang H.-K., Nguyen V. D., Kim Y.-M., Kim D.-W., et al. (2012). Flavonoid-mediated Inhibition of SARS Coronavirus 3C-like Protease Expressed in Pichia pastoris. Biotechnol. Lett. 34 (5), 831\u2013838. 10.1007/s10529-011-0845-8", "ArticleIdList": ["10.1007/s10529-011-0845-8", "PMC7087583", "22350287"]}, {"Citation": "Nishimura Y., Kato K., Furuno K., Himeno M. (1995). Inhibitory Effect of Leupeptin on the Intracellular Maturation of Lysosomal Cathepsin L in Primary Cultures of Rat Hepatocytes. Biol. Pharm. Bull. 18 (7), 945\u2013950. 10.1248/bpb.18.945", "ArticleIdList": ["10.1248/bpb.18.945", "7581248"]}, {"Citation": "O'Keefe B. R., Giomarelli B., Barnard D. L., Shenoy S. R., Chan P. K. S., McMahon J. B., et al. (2010). Broad-spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae. J. Virol. 84 (5), 2511\u20132521. 10.1128/JVI.02322-09", "ArticleIdList": ["10.1128/JVI.02322-09", "PMC2820936", "20032190"]}, {"Citation": "Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., et al. (2020). Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and its Immune Cross-Reactivity with SARS-CoV. Nat. Commun. 11 (1), 1620. 10.1038/s41467-020-15562-9", "ArticleIdList": ["10.1038/s41467-020-15562-9", "PMC7100515", "32221306"]}, {"Citation": "Ovcharenko A. V., Zhirnov O. P. (1994). Aprotinin Aerosol Treatment of Influenza and Paramyxovirus Bronchopneumonia of Mice. Antiviral Res. 23 (2), 107\u2013118. 10.1016/0166-3542(94)90038-8", "ArticleIdList": ["10.1016/0166-3542(94)90038-8", "7511880"]}, {"Citation": "Paraskevis D., Kostaki E. G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S. (2020). Full-genome Evolutionary Analysis of the Novel corona Virus (2019-nCoV) Rejects the Hypothesis of Emergence as a Result of a Recent Recombination Event. Infect. Genet. Evol. 79, 104212. 10.1016/j.meegid.2020.104212", "ArticleIdList": ["10.1016/j.meegid.2020.104212", "PMC7106301", "32004758"]}, {"Citation": "Park H. R., Yoon H., Kim M. K., Lee S. D., Chong Y. (2012a). Synthesis and Antiviral Evaluation of 7-O-Arylmethylquercetin Derivatives against SARS-Associated Coronavirus (SCV) and Hepatitis C Virus (HCV). Arch. Pharm. Res. 35 (1), 77\u201385. 10.1007/s12272-012-0108-9", "ArticleIdList": ["10.1007/s12272-012-0108-9", "PMC7090976", "22297745"]}, {"Citation": "Park J.-Y., Jae Jeong H., Hoon Kim J., Min Kim Y., Park S.-J., Kim D., et al. (2012b). Diarylheptanoids from Alnus Japonica Inhibit Papain-like Protease of Severe Acute Respiratory Syndrome Coronavirus. Biol. Pharm. Bull. 35 (11), 2036\u20132042. 10.1248/bpb.b12-00623", "ArticleIdList": ["10.1248/bpb.b12-00623", "22971649"]}, {"Citation": "Park J.-Y., Kim J. H., Kim Y. M., Jeong H. J., Kim D. W., Park K. H., et al. (2012c). Tanshinones as Selective and Slow-Binding Inhibitors for SARS-CoV Cysteine Proteases. Bioorg. Med. Chem. 20 (19), 5928\u20135935. 10.1016/j.bmc.2012.07.038", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "PMC7127169", "22884354"]}, {"Citation": "Park J.-Y., Ko J.-A., Kim D. W., Kim Y. M., Kwon H.-J., Jeong H. J., et al. (2016). Chalcones Isolated fromAngelica Keiskeiinhibit Cysteine Proteases of SARS-CoV. J. Enzyme Inhib. Med. Chem. 31 (1), 23\u201330. 10.3109/14756366.2014.1003215", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Park J.-Y., Yuk H. J., Ryu H. W., Lim S. H., Kim K. S., Park K. H., et al. (2017). Evaluation of Polyphenols from Broussonetia Papyrifera as Coronavirus Protease Inhibitors. J. Enzyme Inhib. Med. Chem. 32 (1), 504\u2013512. 10.1080/14756366.2016.1265519", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Patel M., Ashraf M. S., Siddiqui A. J., Ashraf S. A., Sachidanandan M., Snoussi M., et al. (2020). Profiling and Role of Bioactive Molecules from Puntius Sophore (Freshwater/Brackish Fish) Skin Mucus with its Potent Antibacterial, Antiadhesion, and Antibiofilm Activities. Biomolecules 10 (6), 920. 10.3390/biom10060920", "ArticleIdList": ["10.3390/biom10060920", "PMC7355610", "32560562"]}, {"Citation": "Patel M., Sachidanandan M., Adnan M. (2019). Serine Arginine Protein Kinase 1 (SRPK1): a Moonlighting Protein with Theranostic Ability in Cancer Prevention. Mol. Biol. Rep. 46 (1), 1487\u20131497. 10.1007/s11033-018-4545-5", "ArticleIdList": ["10.1007/s11033-018-4545-5", "30535769"]}, {"Citation": "Paules C. I., Marston H. D., Fauci A. S. (2020). Coronavirus Infections-More Than Just the Common Cold. JAMA 323 (8), 707\u2013708. 10.1001/jama.2020.0757", "ArticleIdList": ["10.1001/jama.2020.0757", "31971553"]}, {"Citation": "Pfefferle S., Sch\u00f6pf J., K\u00f6gl M., Friedel C. C., M\u00fcller M. A., Carbajo-Lozoya J., et al. (2011). The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors. Plos Pathog. 7 (10), e1002331. 10.1371/journal.ppat.1002331", "ArticleIdList": ["10.1371/journal.ppat.1002331", "PMC3203193", "22046132"]}, {"Citation": "Pillay T. S. (2020). Gene of the Month: the 2019-nCoV/SARS-CoV-2 Novel Coronavirus Spike Protein. J. Clin. Pathol. 73 (7), 366\u2013369. 10.1136/jclinpath-2020-206658", "ArticleIdList": ["10.1136/jclinpath-2020-206658", "32376714"]}, {"Citation": "Prentice E., McAuliffe J., Lu X., Subbarao K., Denison M. R. (2004). Identification and Characterization of Severe Acute Respiratory Syndrome Coronavirus Replicase Proteins. J. Virol. 78 (18), 9977\u20139986. 10.1128/JVI.78.18.9977-9986.2004", "ArticleIdList": ["10.1128/JVI.78.18.9977-9986.2004", "PMC514967", "15331731"]}, {"Citation": "Raj V., Park J. G., Cho K.-H., Choi P., Kim T., Ham J., et al. (2021). Assessment of Antiviral Potencies of Cannabinoids against SARS-CoV-2 Using Computational and In Vitro Approaches. Int. J. Biol. Macromolecules 168, 474\u2013485. 10.1016/j.ijbiomac.2020.12.020", "ArticleIdList": ["10.1016/j.ijbiomac.2020.12.020", "PMC7836687", "33290767"]}, {"Citation": "Roh C. (2012). A Facile Inhibitor Screening of SARS Coronavirus N Protein Using Nanoparticle-Based RNA Oligonucleotide. Ijn 7, 2173\u20132179. 10.2147/IJN.S31379", "ArticleIdList": ["10.2147/IJN.S31379", "PMC3356205", "22619553"]}, {"Citation": "Ruch T. R., Machamer C. E. (2012). The Coronavirus E Protein: Assembly and beyond. Viruses 4 (3), 363\u2013382. 10.3390/v4030363", "ArticleIdList": ["10.3390/v4030363", "PMC3347032", "22590676"]}, {"Citation": "Russo G. L., Tedesco I., Spagnuolo C., Russo M. (2017). Antioxidant Polyphenols in Cancer Treatment: Friend, Foe or Foil? Semin. Cancer Biol. 46, 1\u201313. 10.1016/j.semcancer.2017.05.005", "ArticleIdList": ["10.1016/j.semcancer.2017.05.005", "28511887"]}, {"Citation": "Russo M., Moccia S., Spagnuolo C., Tedesco I., Russo G. L. (2020). Roles of Flavonoids against Coronavirus Infection. Chemico-Biological Interactions 328, 109211. 10.1016/j.cbi.2020.109211", "ArticleIdList": ["10.1016/j.cbi.2020.109211", "PMC7385538", "32735799"]}, {"Citation": "Ryu Y. B., Jeong H. J., Kim J. H., Kim Y. M., Park J.-Y., Kim D., et al. (2010a). Biflavonoids from Torreya Nucifera Displaying SARS-CoV 3CLpro Inhibition. Bioorg. Med. Chem. 18 (22), 7940\u20137947. 10.1016/j.bmc.2010.09.035", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Ryu Y. B., Park S.-J., Kim Y. M., Lee J.-Y., Seo W. D., Chang J. S., et al. (2010b). SARS-CoV 3CLpro Inhibitory Effects of Quinone-Methide Triterpenes from Tripterygium Regelii. Bioorg. Med. Chem. Lett. 20 (6), 1873\u20131876. 10.1016/j.bmcl.2010.01.152", "ArticleIdList": ["10.1016/j.bmcl.2010.01.152", "PMC7127101", "20167482"]}, {"Citation": "Saberi A., Gulyaeva A. A., Brubacher J. L., Newmark P. A., Gorbalenya A. E. (2018). A Planarian Nidovirus Expands the Limits of RNA Genome Size. Plos Pathog. 14 (11), e1007314. 10.1371/journal.ppat.1007314", "ArticleIdList": ["10.1371/journal.ppat.1007314", "PMC6211748", "30383829"]}, {"Citation": "Salminen A., Gottesman M. M. (1990). Inhibitor Studies Indicate that Active Cathepsin L Is Probably Essential to its Own Processing in Cultured Fibroblasts. Biochem. J. 272 (1), 39\u201344. 10.1042/bj2720039", "ArticleIdList": ["10.1042/bj2720039", "PMC1149653", "2264836"]}, {"Citation": "Schoeman D., Fielding B. C. (2019). Coronavirus Envelope Protein: Current Knowledge. Virol. J. 16 (1), 69. 10.1186/s12985-019-1182-0", "ArticleIdList": ["10.1186/s12985-019-1182-0", "PMC6537279", "31133031"]}, {"Citation": "Seybert A., Hegyi A., Siddell S. G., Ziebuhr J. (2000). The Human Coronavirus 229E Superfamily 1 Helicase Has RNA and DNA Duplex-Unwinding Activities with 5\u2032-to-3\u2032 Polarity. RNA 6 (7), 1056\u20131068. 10.1017/s1355838200000728", "ArticleIdList": ["10.1017/s1355838200000728", "PMC1369980", "10917600"]}, {"Citation": "Shen L., Niu J., Wang C., Huang B., Wang W., Zhu N., et al. (2019). High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. J. Virol. 93 (12), e00023\u201300019. 10.1128/JVI.00023-19", "ArticleIdList": ["10.1128/JVI.00023-19", "PMC6613765", "30918074"]}, {"Citation": "Shen L. W., Mao H. J., Wu Y. L., Tanaka Y., Zhang W. (2017). TMPRSS2: A Potential Target for Treatment of Influenza Virus and Coronavirus Infections. Biochimie 142, 1\u201310. 10.1016/j.biochi.2017.07.016", "ArticleIdList": ["10.1016/j.biochi.2017.07.016", "PMC7116903", "28778717"]}, {"Citation": "Shi K., Chen X., Xie B., Yang S. S., Liu D., Dai G., et al. (2018). Celastrol Alleviates Chronic Obstructive Pulmonary Disease by Inhibiting Cellular Inflammation Induced by Cigarette Smoke via the Ednrb/Kng1 Signaling Pathway. Front. Pharmacol. 9, 1276. 10.3389/fphar.2018.01276", "ArticleIdList": ["10.3389/fphar.2018.01276", "PMC6249343", "30498444"]}, {"Citation": "Shi T.-H., Huang Y.-L., Chen C.-C., Pi W.-C., Hsu Y.-L., Lo L.-C., et al. (2020). Andrographolide and its Fluorescent Derivative Inhibit the Main Proteases of 2019-nCoV and SARS-CoV through Covalent Linkage. Biochem. Biophysical Res. Commun. 533 (3), 467\u2013473. 10.1016/j.bbrc.2020.08.086", "ArticleIdList": ["10.1016/j.bbrc.2020.08.086", "PMC7447262", "32977949"]}, {"Citation": "Siddiqui A. J., Danciu C., Ashraf S. A., Moin A., Singh R., Alreshidi M., et al. (2020). Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses. Plants 9 (9), 1244. 10.3390/plants9091244", "ArticleIdList": ["10.3390/plants9091244", "PMC7570315", "32967179"]}, {"Citation": "Siu K.-L., Chan C.-P., Kok K.-H., Chiu-Yat Woo P., Jin D.-Y. (2014). Suppression of Innate Antiviral Response by Severe Acute Respiratory Syndrome Coronavirus M Protein Is Mediated through the First Transmembrane Domain. Cell Mol Immunol 11 (2), 141\u2013149. 10.1038/cmi.2013.61", "ArticleIdList": ["10.1038/cmi.2013.61", "PMC4003381", "24509444"]}, {"Citation": "Skariyachan S., Challapilli S. B., Packirisamy S., Kumargowda S. T., Sridhar V. S. (2019). Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections. Front. Microbiol. 10, 569. 10.3389/fmicb.2019.00569", "ArticleIdList": ["10.3389/fmicb.2019.00569", "PMC6448012", "30984127"]}, {"Citation": "Song Y. H., Kim D. W., Curtis-Long M. J., Yuk H. J., Wang Y., Zhuang N., et al. (2014). Papain-like Protease (PLpro) Inhibitory Effects of Cinnamic Amides from Tribulus Terrestris Fruits. Biol. Pharm. Bull. 37 (6), 1021\u20131028. 10.1248/bpb.b14-00026", "ArticleIdList": ["10.1248/bpb.b14-00026", "24882413"]}, {"Citation": "Stadler K., Masignani V., Eickmann M., Becker S., Abrignani S., Klenk H.-D., et al. (2003). SARS - Beginning to Understand a New Virus. Nat. Rev. Microbiol. 1 (3), 209\u2013218. 10.1038/nrmicro775", "ArticleIdList": ["10.1038/nrmicro775", "PMC7097337", "15035025"]}, {"Citation": "Su H.-x., Yao S., Zhao W.-f., Li M.-j., Liu J., Shang W.-j., et al. (2020). Anti-SARS-CoV-2 Activities In Vitro of Shuanghuanglian Preparations and Bioactive Ingredients. Acta Pharmacol. Sin 41 (9), 1167\u20131177. 10.1038/s41401-020-0483-6", "ArticleIdList": ["10.1038/s41401-020-0483-6", "PMC7393338", "32737471"]}, {"Citation": "Sui H., Yu Q., Zhi Y., Geng G., Liu H., Xu H. (2010). [Effects of Apigenin on the Expression of Angiotensin-Converting Enzyme 2 in Kidney in Spontaneously Hypertensive Rats]. Wei Sheng Yan Jiu 39 (6), 693\u2013696.", "ArticleIdList": ["21351633"]}, {"Citation": "Sung W. S., Lee D. G. (2008). The Combination Effect of Korean Red Ginseng Saponins with Kanamycin and Cefotaxime against Methicillin-Resistant Staphylococcus aureus . Biol. Pharm. Bull. 31 (8), 1614\u20131617. 10.1248/bpb.31.1614", "ArticleIdList": ["10.1248/bpb.31.1614", "18670099"]}, {"Citation": "Takahashi S., Yoshiya T., Yoshizawa-Kumagaye K., Sugiyama T. (2015). Nicotianamine Is a Novel Angiotensin-Converting Enzyme 2 Inhibitor in Soybean. Biomed. Res. 36 (3), 219\u2013224. 10.2220/biomedres.36.219", "ArticleIdList": ["10.2220/biomedres.36.219", "26106051"]}, {"Citation": "Tanner J. A., Watt R. M., Chai Y.-B., Lu L.-Y., Lin M. C., Peiris J. S. M., et al. (2003). The Severe Acute Respiratory Syndrome (SARS) Coronavirus NTPase/Helicase Belongs to a Distinct Class of 5\u2032 to 3\u2032 Viral Helicases. J. Biol. Chem. 278 (41), 39578\u201339582. 10.1074/jbc.C300328200", "ArticleIdList": ["10.1074/jbc.C300328200", "PMC8060950", "12917423"]}, {"Citation": "te Velthuis A. J. W., Arnold J. J., Cameron C. E., van den Worm S. H. E., Snijder E. J. (2010). The RNA Polymerase Activity of SARS-Coronavirus Nsp12 Is Primer Dependent. Nucleic Acids Res. 38 (1), 203\u2013214. 10.1093/nar/gkp904", "ArticleIdList": ["10.1093/nar/gkp904", "PMC2800238", "19875418"]}, {"Citation": "te Velthuis A. J. W., van den Worm S. H. E., Snijder E. J. (2012). The SARS-Coronavirus Nsp7+nsp8 Complex Is a Unique Multimeric RNA Polymerase Capable of Both De Novo Initiation and Primer Extension. Nucleic Acids Res. 40 (4), 1737\u20131747. 10.1093/nar/gkr893", "ArticleIdList": ["10.1093/nar/gkr893", "PMC3287201", "22039154"]}, {"Citation": "Tohya Y., Narayanan K., Kamitani W., Huang C., Lokugamage K., Makino S. (2009). Suppression of Host Gene Expression by Nsp1 Proteins of Group 2 Bat Coronaviruses. J. Virol. 83 (10), 5282\u20135288. 10.1128/JVI.02485-08", "ArticleIdList": ["10.1128/JVI.02485-08", "PMC2682096", "19264783"]}, {"Citation": "Tu Y. (2011). The Discovery of Artemisinin (Qinghaosu) and Gifts from Chinese Medicine. Nat. Med. 17 (10), 1217\u20131220. 10.1038/nm.2471", "ArticleIdList": ["10.1038/nm.2471", "21989013"]}, {"Citation": "Turner A. J., Hiscox J. A., Hooper N. M. (2004). ACE2: from Vasopeptidase to SARS Virus Receptor. Trends Pharmacol. Sci. 25 (6), 291\u2013294. 10.1016/j.tips.2004.04.001", "ArticleIdList": ["10.1016/j.tips.2004.04.001", "PMC7119032", "15165741"]}, {"Citation": "von Brunn A., Teepe C., Simpson J. C., Pepperkok R., Friedel C. C., Zimmer R., et al. (2007). Analysis of Intraviral Protein-Protein Interactions of the SARS Coronavirus ORFeome. PLoS One 2 (5), e459. 10.1371/journal.pone.0000459", "ArticleIdList": ["10.1371/journal.pone.0000459", "PMC1868897", "17520018"]}, {"Citation": "Walls A. C., Park Y.-J., Tortorici M. A., Wall A., McGuire A. T., Veesler D. (2020). Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181 (2), 281\u2013292. 10.1016/j.cell.2020.02.058", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Wang S. C., Chen Y., Wang Y. C., Wang W. J., Yang C. S., Tsai C. L., et al. (2020). Tannic Acid Suppresses SARS-CoV-2 as a Dual Inhibitor of the Viral Main Protease and the Cellular TMPRSS2 Protease. Am. J. Cancer Res. 10 (12), 4538\u20134546.", "ArticleIdList": ["PMC7783773", "33415017"]}, {"Citation": "Wei Y., Wang Y. (2017). Celastrol Attenuates Impairments Associated with Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome (ARDS) in Rats. J. Immunotoxicology 14 (1), 228\u2013234. 10.1080/1547691X.2017.1394933", "ArticleIdList": ["10.1080/1547691X.2017.1394933", "29179596"]}, {"Citation": "Wen C.-C., Kuo Y.-H., Jan J.-T., Liang P.-H., Wang S.-Y., Liu H.-G., et al. (2007). Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus. J. Med. Chem. 50 (17), 4087\u20134095. 10.1021/jm070295s", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "Wrapp D., Wang N., Corbett K. S., Goldsmith J. A., Hsieh C.-L., Abiona O., et al. (2020). Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science 367 (6483), 1260\u20131263. 10.1126/science.abb2507", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Wrobel A. G., Benton D. J., Xu P., Roustan C., Martin S. R., Rosenthal P. B., et al. (2020). SARS-CoV-2 and Bat RaTG13 Spike Glycoprotein Structures Inform on Virus Evolution and Furin-Cleavage Effects. Nat. Struct. Mol. Biol. 27 (8), 763\u2013767. 10.1038/s41594-020-0468-7", "ArticleIdList": ["10.1038/s41594-020-0468-7", "PMC7610980", "32647346"]}, {"Citation": "Wu C.-Y., Jan J.-T., Ma S.-H., Kuo C.-J., Juan H.-F., Cheng Y.-S. E., et al. (2004). Small Molecules Targeting Severe Acute Respiratory Syndrome Human Coronavirus. Proc. Natl. Acad. Sci. 101 (27), 10012\u201310017. 10.1073/pnas.0403596101", "ArticleIdList": ["10.1073/pnas.0403596101", "PMC454157", "15226499"]}, {"Citation": "Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., et al. (2020). A New Coronavirus Associated with Human Respiratory Disease in China. Nature 579 (7798), 265\u2013269. 10.1038/s41586-020-2008-3", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Xia S., Yan L., Xu W., Agrawal A. S., Algaissi A., Tseng C.-T. K., et al. (2019). A Pan-Coronavirus Fusion Inhibitor Targeting the HR1 Domain of Human Coronavirus Spike. Sci. Adv. 5 (4), eaav4580. 10.1126/sciadv.aav4580", "ArticleIdList": ["10.1126/sciadv.aav4580", "PMC6457931", "30989115"]}, {"Citation": "Xiao Y., Ma Q., Restle T., Shang W., Svergun D. I., Ponnusamy R., et al. (2012). Nonstructural Proteins 7 and 8 of Feline Coronavirus Form a 2:1 Heterotrimer that Exhibits Primer-independent RNA Polymerase Activity. J. Virol. 86 (8), 4444\u20134454. 10.1128/JVI.06635-11", "ArticleIdList": ["10.1128/JVI.06635-11", "PMC3318631", "22318142"]}, {"Citation": "Xu C., Ke Z., Liu C., Wang Z., Liu D., Zhang L., et al. (2020). Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server. J. Chem. Inf. Model. 60 (12), 5735\u20135745. 10.1021/acs.jcim.0c00821", "ArticleIdList": ["10.1021/acs.jcim.0c00821", "32786695"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. (2020). Structural Basis for the Recognition of SARS-CoV-2 by Full-Length Human ACE2. Science 367, 1444\u20131448. 10.1126/science.abb2762", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., et al. (2004). Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells. J. Virol. 78 (20), 11334\u201311339. 10.1128/JVI.78.20.11334-11339.2004", "ArticleIdList": ["10.1128/JVI.78.20.11334-11339.2004", "PMC521800", "15452254"]}, {"Citation": "Yin J., Niu C., Cherney M. M., Zhang J., Huitema C., Eltis L. D., et al. (2007). A Mechanistic View of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3C-like Peptidase. J. Mol. Biol. 371 (4), 1060\u20131074. 10.1016/j.jmb.2007.06.001", "ArticleIdList": ["10.1016/j.jmb.2007.06.001", "PMC7094781", "17599357"]}, {"Citation": "Yu M.-S., Lee J., Lee J. M., Kim Y., Chin Y.-W., Jee J.-G., et al. (2012). Identification of Myricetin and Scutellarein as Novel Chemical Inhibitors of the SARS Coronavirus Helicase, nsP13. Bioorg. Med. Chem. Lett. 22 (12), 4049\u20134054. 10.1016/j.bmcl.2012.04.081", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Zang R., Castro M. F. G., McCune B. T., Zeng Q., Rothlauf P. W., Sonnek N. M., et al. (2020). TMPRSS2 and TMPRSS4 Promote SARS-CoV-2 Infection of Human Small Intestinal Enterocytes. Sci. Immunol. 5. 10.1126/sciimmunol.abc3582", "ArticleIdList": ["10.1126/sciimmunol.abc3582", "PMC7285829", "32404436"]}, {"Citation": "Zhang Y.-N., Zhang Q.-Y., Li X.-D., Xiong J., Xiao S.-Q., Wang Z., et al. (2020). Gemcitabine, Lycorine and Oxysophoridine Inhibit Novel Coronavirus (SARS-CoV-2) in Cell Culture. Emerging Microbes & Infections 9 (1), 1170\u20131173. 10.1080/22221751.2020.1772676", "ArticleIdList": ["10.1080/22221751.2020.1772676", "PMC7448857", "32432977"]}, {"Citation": "Zhang Z.-R., Zhang Y.-N., Li X.-D., Zhang H.-Q., Xiao S.-Q., Deng F., et al. (2020). A Cell-Based Large-Scale Screening of Natural Compounds for Inhibitors of SARS-CoV-2. Sig Transduct Target. Ther. 5 (1), 218. 10.1038/s41392-020-00343-z", "ArticleIdList": ["10.1038/s41392-020-00343-z", "PMC7532339", "33011739"]}, {"Citation": "Zhirnov O. P., Klenk H. D., Wright P. F. (2011). Aprotinin and Similar Protease Inhibitors as Drugs against Influenza. Antiviral Res. 92 (1), 27\u201336. 10.1016/j.antiviral.2011.07.014", "ArticleIdList": ["10.1016/j.antiviral.2011.07.014", "21802447"]}, {"Citation": "Zhou P., Li H., Wang H., Wang L.-F., Shi Z. (2012). Bat Severe Acute Respiratory Syndrome-like Coronavirus ORF3b Homologues Display Different Interferon Antagonist Activities. J. Gen. Virol. 93 (Pt 2), 275\u2013281. 10.1099/vir.0.033589-0", "ArticleIdList": ["10.1099/vir.0.033589-0", "22012463"]}, {"Citation": "Ziebuhr J. (2004). Molecular Biology of Severe Acute Respiratory Syndrome Coronavirus. Curr. Opin. Microbiol. 7 (4), 412\u2013419. 10.1016/j.mib.2004.06.007", "ArticleIdList": ["10.1016/j.mib.2004.06.007", "PMC7108451", "15358261"]}, {"Citation": "Ziebuhr J. (2005). \u201cThe Coronavirus Replicase,\u201d in Coronavirus Replication and Reverse Genetics. Editor Enjuanes L. (Berlin, Heidelberg: Springer Berlin Heidelberg; ), 57\u201394. 10.1007/3-540-26765-4_3", "ArticleIdList": ["10.1007/3-540-26765-4_3"]}, {"Citation": "Zi\u00f3\u0142kowska N. E., O'Keefe B. R., Mori T., Zhu C., Giomarelli B., Vojdani F., et al. (2006). Domain-swapped Structure of the Potent Antiviral Protein Griffithsin and its Mode of Carbohydrate Binding. Structure 14 (7), 1127\u20131135. 10.1016/j.str.2006.05.017", "ArticleIdList": ["10.1016/j.str.2006.05.017", "PMC7126681", "16843894"]}, {"Citation": "Zi\u00f3\u0142kowska N. E., Shenoy S. R., O'Keefe B. R., McMahon J. B., Palmer K. E., Dwek R. A., et al. (2007). Crystallographic, Thermodynamic, and Molecular Modeling Studies of the Mode of Binding of Oligosaccharides to the Potent Antiviral Protein Griffithsin. Proteins 67 (3), 661\u2013670. 10.1002/prot.21336", "ArticleIdList": ["10.1002/prot.21336", "PMC7167611", "17340634"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "29"}, {"Year": "2021", "Month": "7", "Day": "12"}, {"Year": "2021", "Month": "9", "Day": "6", "Hour": "5", "Minute": "54"}, {"Year": "2021", "Month": "9", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "8", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["34483904", "PMC8416071", "10.3389/fphar.2021.702472", "702472"]}}], "PubmedBookArticle": []}